# Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

> **NCT06975969** · — · WITHDRAWN · sponsor: **Liquet Medical Inc.**

## Conditions studied

- Blood Clots
- Vascular Disease
- Embolism Thrombosis
- Cardiovascular Diseases
- Lung Diseases

## Interventions

- **DEVICE:** Versus™ Endovascular Pulmonary Artery Drug Delivery Catheter

## Key facts

- **NCT ID:** NCT06975969
- **Lead sponsor:** Liquet Medical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-09-05
- **Primary completion:** 2026-02-20
- **Final completion:** 2026-02-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled.
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06975969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06975969, "Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06975969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*